second line bladder cancer therapies when first line treatments fail
Published 5 years ago • 1.5K plays • Length 19:31Download video MP4
Download video MP3
Similar videos
-
19:21
immunotherapy for muscle invasive bladder cancer
-
20:52
bladder cancer and immunotherapy
-
24:15
bladder cancer and immunotherapy
-
3:32
updates on immunotherapy for bladder cancer
-
21:28
bcg failure defining and managing difficult patients
-
10:35
management of bcg unresponsive cystectomy ineligible bladder cancer patients pembrolizumab
-
19:16
diagnosis & treatment of non-muscle invasive bladder cancer: aua/suo guidelines
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
25:33
immunotherapeutic agents in metastatic bladder cancer
-
6:09
enfortumab vedotin for previously-treated advanced urothelial carcinoma
-
21:10
prioritizing the optimal therapy for t1 bladder cancer: using the old and new
-
1:36
evaluating second-line treatment options in bladder cancer
-
44:45
systemic treatment of bladder cancer: the benefits of clinical pathways
-
21:04
bcg unresponsive non-muscle invasive bladder cancer
-
22:33
approaches to the treatment of advanced bladder cancer
-
55:15
2.22.2021 urology covid didactics - immunotherapy for bladder cancer
-
54:20
advances in the treatment of metastatic bladder cancer
-
43:17
case-based panel discussion: muscle-invasive bladder cancer
-
14:50
bcg unresponsive disease